Flare Phenomenon After 177 Lu-DOTA-IBA Therapy in Bone Metastases of Lung Cancer.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 38886924.
- Also identified by DOI 10.1097/RLU.0000000000005303.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The flare phenomenon is a transient increase in the number or intensity of lesions on bone scans after treatment, signifying curative effect. DOTA-ibandronic acid (DOTA-IBA) is a new prodrug that targets bone metastases and can be labeled with 177 Lu. Here, we report the case of a 58-year-old woman with bone metastasis, in whom the flare phenomenon was observed after 4 cycles of 177 Lu-DOTA-IBA treatment. No adverse effects were observed during the treatment and follow-up periods.
Medical subject headings
- Bone Neoplasms
- Lung Neoplasms